Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Ganser, K; Klumpp, L; Bischof, H; Lukowski, R; Eckert, F; Huber, SM.
Potassium Channels in Cancer.
Handb Exp Pharmacol. 2021; 267: 253-275.
Doi: 10.1007/164_2021_465
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Bischof Helmut
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Neoplastic transformation is reportedly associated with alterations of the potassium transport across plasma and intracellular membranes. These alterations have been identified as crucial elements of the tumourigenic reprogramming of cells. Potassium channels may contribute to cancer initiation, malignant progression and therapy resistance of tumour cells. The book chapter focusses on (oncogenic) potassium channels frequently upregulated in different tumour entities, upstream and downstream signalling of these channels, their contribution to the maintenance of cancer stemness and the formation of an immunosuppressive tumour microenvironment. In addition, their role in adaptation to tumour hypoxia, metabolic reprogramming, as well as tumour spreading and metastasis is discussed. Finally, we discuss how (oncogenic) potassium channels may confer treatment resistance of tumours against radiation and chemotherapy and thus might be harnessed for new therapy strategies, for instance, by repurposing approved drugs known to target potassium channels.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Neoplasms - drug therapy
-
Potassium Channels - administration & dosage
-
Signal Transduction - administration & dosage
-
Tumor Microenvironment - administration & dosage